Arab Drug Balance Sheet Health
Financial Health criteria checks 4/6
Arab Drug has a total shareholder equity of EGP431.5M and total debt of EGP538.7M, which brings its debt-to-equity ratio to 124.9%. Its total assets and total liabilities are EGP1.2B and EGP766.8M respectively. Arab Drug's EBIT is EGP129.6M making its interest coverage ratio -32.1. It has cash and short-term investments of EGP186.6M.
Key information
124.9%
Debt to equity ratio
ج.م538.74m
Debt
| Interest coverage ratio | -32.1x |
| Cash | ج.م186.60m |
| Equity | ج.م431.48m |
| Total liabilities | ج.م766.75m |
| Total assets | ج.م1.20b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: ADCI's short term assets (EGP670.1M) exceed its short term liabilities (EGP461.4M).
Long Term Liabilities: ADCI's short term assets (EGP670.1M) exceed its long term liabilities (EGP305.4M).
Debt to Equity History and Analysis
Debt Level: ADCI's net debt to equity ratio (81.6%) is considered high.
Reducing Debt: ADCI's debt to equity ratio has increased from 5.5% to 124.9% over the past 5 years.
Debt Coverage: ADCI's debt is well covered by operating cash flow (26.3%).
Interest Coverage: ADCI earns more interest than it pays, so coverage of interest payments is not a concern.